|
|
[Journal Briefing] Ŭ·ÎÇǵµ±×·¼, ¾Æ½ºÇǸ° ´ë¾ÈÀÌ µÉ ¼ö ÀÖÀ»±î? |
Á¤¿¬ÁÖ ±âÀÚ |
2024-02-07 14:13 |
[Journal Briefing] Ŭ·ÎÇǵµ±×·¼, PCI ¹ÞÀº °íÀ§Çè ȯÀÚ¿¡¼µµ ¿ì¼öÇÒ±î? |
Á¤¿¬ÁÖ ±âÀÚ |
2024-01-23 16:46 |
[Drug Review] ¾ÆÁ©´ÏµðÇÉÀÇ Ç¥ÀûÀå±â º¸È£È¿°ú Ç÷°ü¿¡¼ ½ÉÀ塤½ÅÀå±îÁö |
ÀÌ»óµ· ±âÀÚ |
2023-12-07 13:33 |
[Cover Story] Çѱ¹ÀÎ ³úÁ¹Áß, ¼¾ç°ú À¯º´Æ¯¼º ´Ù¸£´Ù |
ÀÌ»óµ· ±âÀÚ |
2023-07-05 16:49 |
[Interview] Çѱ¹ÀÎ ACS ȯÀÚ, ¸ÂÃãÇü DAPT Àü·« ÇÊ¿äÇÏ´Ù |
ÀÓ¼¼Çü ±âÀÚ |
2023-07-05 14:54 |
¶óÀÎ |
[Late Breaking Studies] ½ºÅ¸Æ¾ vs ½ºÅ¸Æ¾ + ¿¡Á¦Æ¼¹Ìºê ±Ù°Å¿Í ÇöÁÖ¼Ò Â¤¾îº¸±â |
ÀÓ¼¼Çü ±âÀÚ |
2023-05-04 16:11 |
[Sub Story] ¡®LABA/LAMA¡¯, COPD °ü¸® ÇÙ½ÉÀü·«À¸·Î |
ÀÓ¼¼Çü ±âÀÚ |
2023-04-03 17:56 |
[Sub Story] ±¹³» õ½Ä Áø·áÁöħ, ICS/LABA ºñÁß À¯Áö |
ÀÓ¼¼Çü ±âÀÚ |
2023-04-03 17:39 |
[Interview] Áö³ 10³â ¡®½ºÅ¸Æ¾°ú ´ç´¢º´ À§Ç衯 ´ã·Ð ÇâÈÄ 10³â ½ºÅ¸Æ¾/ºñ½ºÅ¸Æ¾°è·Î |
ÀÌ»óµ· ±âÀÚ |
2023-03-10 16:19 |
[Sub Story] PPI ¾ÈÀü¼º È®ÀÎ, ¾ÆÁ÷ ³¡³ªÁö ¾Ê¾Ò´Ù? |
ÀÓ¼¼Çü ±âÀÚ |
2023-01-06 18:00 |
¶óÀÎ |
[Interview] ÀÌ»óÁöÁúÇ÷Áõ °í·É¡¤½Å±ÔȯÀÚ Áõ°¡ |
ÀÌ»óµ· ±âÀÚ |
2022-05-03 14:35 |
[Sub Story] 3Á¦¿ä¹ý, ¸®¾ó¿ùµå ÁßÁõ ¾ÇÈ È¯ÀÚ¿¡¼ ÀÏ°üµÈ ÇýÅà |
ÀÓ¼¼Çü ±âÀÚ |
2022-04-11 14:29 |
[Conference Report] ´ëÇѼÒȱâ±â´É¼ºÁúȯ¡¤¿îµ¿ÇÐȸ 'APNM 2022' °³ÃÖ |
ÀÓ¼¼Çü ±âÀÚ |
2022-03-10 14:30 |
[Deep in Guideline] Ŭ¶ó¸®½º·Î¸¶À̽Š³»¼º·ü °í·ÁÇÑ ºñ½º¹«½º 4Á¦¿ä¹ý ±Ç°í |
ÀÓ¼¼Çü ±âÀÚ |
2022-01-04 14:28 |
[Drug Review] Ç×Ç÷Àü¿ä¹ý, ÀûÀýÇÑ PPI ¼±ÅÃÀ¸·Î ¿Ï¼ºµÈ´Ù |
ÀÓ¼¼Çü ±âÀÚ |
2021-08-09 17:40 |
¶óÀÎ |
[Sub Story] ¸¸¼ºÁúȯ °ñ´Ù°øÁõ °ñÀý À§Çè, °ñ¹Ðµµ °¨¼Ò ¿¹Ãøº¸´Ù ³ôÀ» ¼ö ÀÖ¾î |
THE MOST |
2021-07-02 10:33 |
[KSCMS] ´ç´¢º´ ȯÀÚÀÇ ½ÉÇ÷°üÁúȯ ¿¹¹æ - ¼º±Õ°üÀÇ´ë ¹Ú¼¼Àº ±³¼ö |
THE MOST |
2021-06-04 15:52 |
[Cover Story] K-hypertension À§±â¿Í ±âȸ |
ÀÌ»óµ· ±âÀÚ |
2021-05-11 19:09 |
[Interview] ¡°°·ÂÇÑ ARB ¾ÆÁú»ç¸£Åº, 1¡¤2±â°íÇ÷¾Ð 1Â÷Àü·«À¸·Î Àû¿ë °¡´É¡± |
ÀÓ¼¼Çü ±âÀÚ |
2021-05-11 16:23 |
[Conference Report] Áö¹æ°£ ¹× °£¼¶À¯ÈÁõ Ä¡·áÀü·« |
ÀÓ¼¼Çü ±âÀÚ |
2021-01-22 10:34 |
|